Unia Europejska - czeski - EMA (European Medicines Agency)

diurnal europe b.v. - hydrokortison - adrenal hyperplasia, congenital - kortikosteroidy pro systémové použití - treatment of congenital adrenal hyperplasia (cah) in adolescents aged 12 years and over and adults.

Unia Europejska - czeski - EMA (European Medicines Agency)

pinax pharma gmbh - joflupan (123i) - radionuclide imaging; dementia; movement disorders - diagnostické radiofarmaka - tento léčivý přípravek je určen pouze pro diagnostické účely. celsunax is indicated for detecting loss of functional dopaminergic neuron terminals in the striatum:in adult patients with clinically uncertain parkinsonian syndromes, for example those with early symptoms, in order to help differentiate essential tremor from parkinsonian syndromes related to idiopathic parkinson’s disease, multiple system atrophy and progressive supranuclear palsy.  celsunax is unable to discriminate between parkinson's disease, multiple system atrophy and progressive supranuclear palsy. u dospělých pacientů, pomoci odlišit pravděpodobné demence s lewyho tělísky od alzheimerovy choroby.  celsunax is unable to discriminate between dementia with lewy bodies and parkinson’s disease dementia.

Unia Europejska - czeski - EMA (European Medicines Agency)

biomarin international limited - vosoritide - achondroplasia - léky na léčbu nemocí kostí - voxzogo is indicated for the treatment of achondroplasia in patients 4 months of age and older whose epiphyses are not closed. the diagnosis of achondroplasia should be confirmed by appropriate genetic testing.

Unia Europejska - czeski - EMA (European Medicines Agency)

bial portela & companhia s.a. - opicapone - parkinsonova choroba - antiparkinsonické léky - ontilyv is indicated as adjunctive therapy to preparations of levodopa/ dopa decarboxylase inhibitors (ddci) in adult patients with parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.

Unia Europejska - czeski - EMA (European Medicines Agency)

lipomed gmbh - thalidomid - mnohočetný myelom - imunosupresiva - thalidomide lipomed in combination with melphalan and prednisone is indicated as first line treatment of patients with untreated multiple myeloma, aged ≥ 65 years or ineligible for high dose chemotherapy. thalidomide lipomed is prescribed and dispensed in accordance with the thalidomide lipomed pregnancy prevention programme (see section 4.

Czechy - czeski - SUKL (Státní ústav pro kontrolu léčiv)

leros, s.r.o., praha 5-zbraslav array - 2292 naŤ jmelÍ; 2280 tŘezalkovÁ naŤ; 2243 hlohovÝ list s kvĚtem; 2253 hlohovÝ plod; 2277 pŘesliČkovÁ naŤ; 2286 naŤ mÁty peprnÉ; 2284 meduŇkovÁ naŤ; 289 heŘmÁnkovÝ kvĚt - léčivý čaj - fytofarmaka a ŽivoČiŠnÉ produkty (ČeskÁ atc skupina)

Czechy - czeski - SUKL (Státní ústav pro kontrolu léčiv)

egis pharmaceuticals plc, budapešť array - 2571 jodovanÝ povidon - Čípek - 200mg - jodovanÝ povidon

Czechy - czeski - SUKL (Státní ústav pro kontrolu léčiv)

krka, d.d., novo mesto, novo mesto array - 174 bisakodyl - obalená tableta - 5mg - bisakodyl

Czechy - czeski - SUKL (Státní ústav pro kontrolu léčiv)

bayer s.r.o., praha array - 4690 bifonazol - kožní roztok - 0,01g/g - bifonazol

Czechy - czeski - SUKL (Státní ústav pro kontrolu léčiv)

pierre fabre medicament, lavaur array - 5849 hexamidin-diisetionÁt; 9861 roztok chlorhexidin-diglukonÁtu; 313 chlorkresol - kožní tekutina - 0,25g/0,25g/0,75g - chlorhexidin, kombinace